Gastroenterology Research and Practice

Gastroenterology Research and Practice / 2019 / Article

Review Article | Open Access

Volume 2019 |Article ID 5698532 | 13 pages |

Upper Gastrointestinal Manifestation of Bezoars and the Etiological Factors: A Literature Review

Academic Editor: Vincenzo Pilone
Received01 Jan 2019
Revised28 Apr 2019
Accepted09 May 2019
Published15 Jul 2019


A gastric bezoar is a compact mass of indigestible foreign materials that accumulate and consolidate in the stomach; however, it can be found in other sites of the gastrointestinal tract. The causative manner of this condition is complex and multifactorial. The main purpose of the review was to raise awareness among clinicians, particularly gastroenterologists, that patients with certain risk factors or comorbid conditions are predisposed to gastric bezoar formation. Early diagnosis and prompt intervention are crucial to avoid bezoar-induced complications. Upper gastrointestinal endoscopy is the standard diagnostic and therapeutic method for gastric bezoars. However, for large size bezoars, surgical intervention is needed.

1. Introduction

Bezoars are congregations or compact masses that formed by the accumulation of matter, especially nonedible materials, including high-fiber vegetable diet, hair, and certain pharmaceutical agents. They are found more frequently in the stomach in patients with normal or abnormal gastric function or in patients with poor gastric peristalsis resulting in delayed gastric draining and other associated disorders [1, 2].

The majority of gastric bezoars are found to be present in adolescents and young ladies with a history of pica, predominantly psychiatric disorders. In contrast to adults, the majority of gastric bezoars are associated with gastroparesis, anatomical abnormalities, and former gastric surgeries that reduced gastric motility and ultimately resulting in delayed stomach emptying [1].

The most common clinical presenting symptoms in patients with gastric bezoars include nausea and vomiting, epigastric pain, dyspepsia, and weight loss [1, 3]. They can also be discovered accidentally in asymptomatic patients who undergo upper gastrointestinal (GI) endoscopic evaluation for other indications.

1.1. Etiological Factors and Classifications

Bezoars occur most commonly in people with certain risk factors (Table 1) [414] or in patients with coexisting medical disorders (Table 2) [2, 12, 1444].

Fibers rich dietMilk productsMedicationsPica consumptionMastication disordersInsufficient fluid intakeHoneycomb consumption

Risk factorsVegetariansSynthetic milkOverdose medicinesNonnutritive constituentsDental statusElder peoplePatients with large quantity of honeycomb ingestion for multiple health benefits
Fiber-rich fruitsFeeding methodMedication for suicidal attemptPregnant women and small childrenAbnormal masticationLabors in hot climate
Patient with partial gastrectomy on a high-fiber dietPremature birthBulk-forming agentsPatients with autismDenture wearersInadequate fluid ingestion
Failure to thriveExtended-release medicationsPatients with bariatric surgeryKidney disease
Anemic children

Medical disordersAnatomic abnormalitiesGastric motility disorders

Comorbid conditionsRapunzel syndrome
Anorexia nervosa & bulimia nervosa
Sickle cell & gastrointestinal amyloidosis
Diabetes mellitus & cystic fibrosis
Guillain–Barre syndrome & Bouveret’s syndrome
Hypothyroidism & renal failure
Scleroderma & myotonic dystrophy
Ménétrier’s disease
Hypochlorhydria or achlorhydria
Gastric diverticula
Gastric outlet obstruction
Pyloric stenosis
Cholecystogastric fistula
Cholecystoduodenal fistula
Diabetic gastroparesis
Idiopathic gastroparesis
Postsurgical gastroparesis
Previous gastric surgeries

Bezoars are categorized according to the following materials that form them. (1)Phytobezoars or diospyrobezoar: composed of indigestible fruit or vegetable content(2)Trichobezoars: composed of hair(3)Lactobezoars: composed of milk products(4)Pharmacobezoars: composed of tablets and medications

Hypothetically, the partially digested and undigested materials accompanied by gastric mucus can be a source of gastric bezoar.

2. Risk Factors

2.1. High Fiber Diet

Diets with high-fiber content (vegetables and fruits, i.e., cellulose) are more common in regions where cultures/beliefs play a key role in consumption [4]. A high-fiber diet has many benefits and is being suggested by health care institutions. Though this suggestion is appropriate for wider consumers and especially the aged population [45], the people with previous gastric surgeries should avoid high-fiber intake because they are more likely to form gastric phytobezoars. These fibers are found in fruits and vegetables including celery, pumpkin, green beans, prunes, raisins, leeks, beets, and sunflower seed shells that are merged into a mass and most often contribute to the development of gastric bezoar [3]. A specific kind of phytobezoar named a diospyrobezoar is made from unripened persimmons, coconuts, and jujubes [1, 5]. A gastric bezoar has also been reported in a patient taking vegetable-derived oil touted to contain lecithin for health purposes in lowering cholesterol levels and improving memory [46].

2.2. Undigested Milk Products

A gastric lactobezoar is a mass composed of a specific form of inspissated milk and mucus components [6]. This type of bezoar is commonly discovered in premature kids receiving formula diets [8]. The pathogenesis is usually complex, involving both exogenous and endogenous risk factors (i.e., synthetic milk, feeding methods, dehydration, premature birth, low birth weight, and insufficient activity and capacity of the GI tract) [6, 7]. Rarely, gastric bezoars may develop in pediatric patients with failure to thrive and iron deficiency anemia due to malnutrition [43]. Moreover, recent advances in artificial milk conformation, mother’s education, and improvements in premature newborn management dramatically affected the incidence of gastric lactobezoar.

2.3. Pharmaceutical Agents

Pharmacobezoars are characterized by aggregations of medicines that do not properly liquefy in the GI tract and can be found in patients taking a pharmaceutical agent, tablets or somewhat liquid masses of drugs; they are usually found following an overdose of medications or in a suicidal attempt [9]. The most frequently involved medication in this entity is bulk-forming hygroscopic laxatives, e.g., perdiem and psyllium preparations, guar gum [6]. Because of the advancement of technology and time delivery-facilitated drug tablets/capsules to be slowly dissolved and gradually release active ingredients of the medication, extended-release medicines, e.g., nifedipine and verapamil, are coated with cellulose acetate; cellulose acetate may amass and lead to the progression of gastric bezoar [6]. Moreover, aluminum hydroxide gel, enteric-coated aspirin, sucralfate, cholestyramine, enteral feeding formulas, mesalamine pills, and meprobamate appear to contribute to the development of pharmacobezoars [47, 48]. Furthermore, a case by Croitoru et al. [10] reported a sodium polystyrene sulfonate gastric bezoar in a patient who mechanically ventilated after cardiopulmonary resuscitation secondary to pericarditis, primary lung cancer, and kidney failure with concomitant hyperkalemia.

2.4. Pica Ingestion

Pica consumption is closely linked to buildup gastric mass characterized by mainly nonnutritious materials, such as ice, pagophagia; paper, papyrophagia; drywall or paint; metal, metallophagia; stones, lithophagia; soil, geophagia; glass, hyalophagia; feces, coprophagia; and chalk. Pica consumption is most frequently found in pregnant women, small children, and those with developmental abnormalities, such as autism [11]. Children ingesting painted plaster may suffer brain damage and learning disabilities from lead poisoning. Furthermore, there is a high risk of GI obstruction or tearing in the stomach. Pica has recently been reported in patients with postbariatric surgery, who presented with pagophagia [49].

2.5. Impaired Mastication

Mastication is a multifactorial semiautonomic sensory motor pathway by which food content is converted into a bolus throughout the course of intraoral manipulation. Influencing factors involve dental status, active adaptation in conducting mastication during bolus formation and properties amalgamation of a bolus which may increase the possibility of GI diseases and reduce gut absorption. Mastication efficacy in denture wearers and dentate subjects is vastly different. In denture wearers, the mastication is known to be highly impaired during bolus formation. In addition to abnormal chewing behaviors and gastric motility, delay gastric emptying occurs due to large fragmented gastric bolus and consequently multiple gastric anomalies [12, 13].

2.6. Inadequate Fluid Intake

Fluids play a critical role in the regularity and the avoidance of GI disorders. Dietary fluid intake and renal excretion regulate total body sodium content. Inadequate fluid intake causes low blood pressure, constipation, kidney disease, electrolyte imbalance, mental changes, and dry stomach. Adequate fluids provide the source for the production of mucus in the GI tract and keep things lubricated and moistened, and thereby, the food bolus and stool can easily move through the GI tract and thus prevented GI disorders [14]. In addition, aged people and the people who work in hot climates are susceptible to dehydration and malnourishment due to age factors, economic status, and environmental factors.

2.7. Honeycomb Ingestion

Recently, honeycomb consumptions are widely used for various health purposes such as heart diseases, liver diseases, and metabolic disorder. However, ingesting a huge quantity of honeycomb may cause GI obstruction and life-threatening consequences. Moreover, Katsinelos et al. [14] reported a patient with irritable bowel syndrome who consumed a large quantity of honeycomb for relieving the symptoms and eventually developed a giant gastric bezoar.

3. Comorbid Conditions

3.1. Coexisting Medical Disorders
3.1.1. Psychiatric Disorders

Trichobezoar commonly appears in patients with a history of Rapunzel syndrome. In this condition, patients have significant psychological or behavioral abnormalities most commonly found in females and can be associated with trichotillomania and trichotillophagia (urge to pullout one’s own hair) combined with trichophagia [2, 17]. Rarely, recurrent trichobezoar may link with animals’ feet stew with skin and hair intact [15]. Gastric bezoars with anorexia nervosa, bulimia nervosa [1618], and sickle cell disease [19] have also been reported in this entity.

3.1.2. Gastrointestinal Amyloidosis

Amyloidosis is a condition caused by deposition of unsolvable abnormal (misfolded protein) amyloid fibrils that modify the normal function of organs and tissues [20]. The small bowel is the most common site for amyloid deposits [21]. Numerous endoscopic features of gastric amyloidosis are nonspecific. Findings include erosions, ulcerations, thickened gastric folds, friability, edema, and submucosal hematoma [50]. The delay of gastric emptying can be the result of several causes. However, amyloid light-chain amyloidosis and amyloid A amyloidosis subtype [21] can cause abnormal GI peristalsis that consequently delayed emptying of food from the stomach and leads to the formation of bezoar [20].

Certain comorbid conditions [11] such as diabetes mellitus, cystic fibrosis, Guillain–Barre syndrome, Bouveret’s syndrome, hypothyroidism, renal failure, scleroderma, myotonic dystrophy, Ménétrier’s disease, multiple myeloma, and hypochlorhydria or achlorhydria have been associated with a higher risk of bezoar formation. (1) Diabetes mellitus is a disorder that causes gastroparesis as a specific complication of diabetes which does not seem to raise the mortality rate. The series of gastric motor irregularities among diabetic patients like irregular distribution of gastric food, a decreased incidence of the antral element that induces antral hypomotility, antral dilatation, fasting, postprandial hypomotility, electrical dysrhythmias, reduced fundic tone, and hyperglycemia can delay gastric emptying [44]. (2) Cystic fibrosis is a hereditary condition that causes intense damage to the lungs, gastrointestinal system (malabsorption), and other organs in the body. Cystic fibrosis potentially dysfunction exocrine gland cells, including mucus-producing cells, sweat, and cells of digestive enzymes. According to Ong et al. [22], these secreted fluids of exocrine glands are generally thin and greasy. But in people with cystic fibrosis, a faulty gene cystic fibrosis transmembrane conductance regulator protein causes the secretions to become sticky, thick, and block lumens. (3) Guillain–Barre syndrome is however rarely associated with a gastric mass and characterized by an acute inflammatory demyelinating polyneuropathy, affecting the peripheral nervous system which leads to weakness and loss of tendon reflexes, dysphagia, difficulty in chewing, and loss of sphincter functions [23]. (4) Bouveret’s syndrome is a very rare form of gallstone ileus caused by the passage and impaction of a large gallstone which passes into the duodenal bulb through a cholecystogastric or cholecystoduodenal fistula and ultimately blocks gastric outflow [24, 25]. Gastric-outlet-obstruction can be due to bacterial infection or gastric wall abscess after cholecystitis [26]. (5) Hypothyroidism, myxoedema or underactive thyroid, is mostly seen in women and is believed to cause gastric bezoar. It is a condition causing slowdown metabolism, GI upset, constipation, etc. [27]. (6) Renal failure is one of the leading causes of delayed gastric emptying and gastric stasis, especially in uremic patients and uremic neuropathy that are so common in these patients [28, 29]. (7) Scleroderma is a prolonged autoimmune disease that is usually associated with abnormal GI motility more commonly in patients with diffuse or limited scleroderma which causes malabsorption, weight loss, severe malnutrition, and delayed gastric emptying in the absence of a mechanical obstruction [30, 31]. (8) Myotonic dystrophy or muscular dystrophy is known to cause GI motility disorder such as edema, atrophy, and fibrosis of smooth muscles of the GI tract. The most common is the Duchenne muscular dystrophy. It is a long-term genetic disorder that affects the function muscles characterized by progressive destruction of striated muscular fibers that may often contract and/or unable to relax [32, 33]. (9-10) Rarely, intragastric bezoar may be associated with multiple myeloma [51] and Ménétrier’s disease [34]. Ménétrier’s disease is a rare condition characterized by gyriform or nodular enlargement of gastric mucosal folds and protein-losing hypertrophic gastroenteropathy. (11) Hypochlorhydria [14] or achlorhydria is a condition of a mild or complete absence of hydrochloric acid in gastric secretions of the stomach and other digestive organs due to dietary factors or medical interventions, respectively. This results in impaired digestion and numerous other effects on the GI tract. Moreover, hypomotility and hyposecretion are the two most significant factors in gastric bezoar formation.

3.2. Anatomic Abnormalities
3.2.1. Gastric Diverticula

A gastric diverticulum is a rare cause of gastric bezoar when a bulk of undigested food remnant expelled from the diverticula of size (1-10 cm). It can be categorized into congenital type and acquired type. The congenital type being more common and less involved in gastric mass formation compared to acquired type is mostly found in the posterior wall of the fundus and account for about 70%. The false diverticula are usually located in the gastric antrum and greater curvature with a contextual history of chronic GI diseases, such as peptic ulcer, pancreatitis, malignancy [52], surgical management with amputation, and gastric segmental resection [35, 36].

3.2.2. Pyloric Stenosis

Pyloric stenosis is a tightening of the pyloric canal most frequently found in infants with a cesarean section or preterm birth [53]. The etiology of pyloric stenosis is complex, with some genetic and some environmental factors. Adults with pyloric stenosis may be due to the idiopathic hypertrophic pylorus [37] or related to underlying gastric pathology such as recurrent peptic ulcers, malignancy, and hypertrophic gastritis that weakens gastric emptying into the duodenum; as a result, all consumed foodstuff stuck in the stomach due to the pyloric obstruction and developed gastric mass [48]. Pyloric obstruction can also be a result of Bouveret’s syndrome [24] and bacterial infection of the gastric wall or gastric wall abscess after cholecystitis [26]. Endoscopic submucosal dissection of the pyloric ring has also been found to be a risk factor for pyloric stenosis [38].

Rarely, gastric bezoars formed when gallstone migrated to the stomach through a cholecystogastric fistula [39] or cholecystoduodenal fistula after endoscopic retrograde cholangiopancreatography [12]. In most cases, the gallstone enters the duodenum through a cholecystoduodenal fistula followed by retrograde migration to the stomach. Small stones are generally eliminated via the stools, and stones measuring more than 2.5 cm are likely to cause obstruction [54]. The most common clinical manifestation is an acute obstruction, either at the duodenum bulb, causing pyloric obstruction, or at the ileum, causing gallstone ileus. Diabetic diathesis might be the major risk factor accountable for producing the pathologic derangement of the gallbladder and stomach and earlier history of gastroparesis, which led to the formation of bezoar and severe complications [39].

3.3. Gastric Dysmotility
3.3.1. Gastroparesis

Gastroparesis or gastric stasis is a disorder that affects gastric muscle activity, and consequently, foodstuff rests in the stomach for a prolonged time [41]. The causative factor of gastric stasis is usually unknown. However, the gastric motor defect may result from autonomic neuropathy, enteric neuropathy; defective interstitial cells of Cajal, diabetes mellitus, develop gastroparesis or idiopathic gastroparesis [40]. Moreover, postoperative gastroparesis is often caused by damage to the vagus nerve.

3.3.2. Previous Gastric Surgeries

The majority of gastric bezoars develop in patients with previous gastric surgeries such as Laparoscopic adjustable gastric banding [42, 43] and Roux-en-Y gastric bypass [55, 56]. Bezoars can develop months to years postoperatively. People, who undergo surgical procedures for bariatric surgery, and particularly partial gastrectomy for gastric cancer are prone to form gastric bezoars due to reduced gastric motility, loss of antral-pyloric function, hypoacidity, and rarely vagotomy that are the major causes of gastric stasis [14, 57].

4. Diagnostic Workup

Gastric bezoars are usually asymptomatic. They are rarely suspected by referring clinicians except in psychiatric patients. They often cause ulceration due to pressure necrosis, pyloric obstruction, peritonitis, and rarely perforation [2, 3, 58] (Figures 1(a) and 1(b)). Therefore, prompt diagnosis and early management of gastric bezoars are essential. A summary of case studies regarding gastric bezoars is presented in Table 3.

Case no. A/G
[ref no.]
History/previous operationSymptomsClinical findingsLocations of bezoar in the stomachSize of bezoar (cm)Associated gastric lesionsComposition of the bezoarManagementComplications

(1) 49/M [1]Habitual jujubes ingestionEpigastric pain
Nausea and vomiting
Gastric reflux
Abdominal tenderness
BodyNecrotic ulcerJujubes (diospyrobezoar)Coca-Cola
(2) 18/F [2]Trichophagia (Rapunzel syndrome)Acute abdominal pain
Weight lossFull-length120 cmUlcerHair (trichobezoar)LaparotomyGastric perforation
(3) 47/M [3]6-monthEpigastric painWeight lossBodyNonePhloem fibers
Raw stinging nettle (phytobezoar)
(4) 76/M [4]Arterial hypertensionDyspepsia
Epigastric pain
NoneBody10 cmUlcerVegetable fibers (phytobezoar)Endoscopic (polypectomy snare)None
(5) M [46]NoneAbdominal pain
Early satiety
Weight lossBodyN/ANoneFatty acids and lecithin (phytobezoar)Surgical removalNone
(6) 96 cases
Low birth weight
Abdominal distension
Palpable abdominal massN/AN/ANoneHigh casein content 54.2%, medium chain triglycerides 54.2%
Caloric density 65.6% (lactobezoars)
Cessation of oral feedings administration of intravenous fluids
Gastric lavage surgery
Perforations (7 patients)
(7) 44/F [9]Anxiety disorderSemiconscious
Fast breathing
Potassium overdose (hyperkalemia)
Bp-89/59 mmHg
Pulse 82/min, resp. 20/min
Gastric fundusN/ANoneExtended-release potassium chloride (pharmacobezoar)Whole bowel irrigation using polyethylene glycol (NG tube)
Upper GI endoscopic removal of pharmacobezoar
(8) 60/F [47]Open cholecystectomy and choledicholithotomyEpigastric pain
Mildly anemic
Epigastric tenderness
Pyloric canalN/ANoneAluminum hydroxide tablets (pharmacobezoar)Endoscopic removal using biopsy forceps and Dormia basketNone
(9) 58/M [48]3-month
Suspected Crohn’s disease
Abdominal pain
Circumferential wall thickening of pylorusPylorusN/AGastritis noncaseating epithelioid
Multiple hyperplastic polyps
Mesalamine pills (pharmacobezoar)Laparoscopic gastrojejunostomyGastric outlet obstruction
(10) 54/M [10]Primary lung cancer (metastatic)
Mechanically ventilated
HyperkalemiaConstrictive effusive metastatic pericarditis kidney failureBodyNoneSodium polystyrene sulfonate (pharmacobezoar)PostmortemExpired
(11) 7/M [11]PicaAbdominal pain
Abdominal tenderness guardingFull-length gastric bezoarNoneWooden bezoarLaparoscopic
Psychiatric evaluation
Gastric perforation
(12) 53/F [49]Pica
(anxiety, depression)
Roux-en-Y gastric bypass
Severe personality disorders
Mild abdominal distentionN/ANoneCardboard and newspaperEndoscopic removal
Psychiatric evaluation
(13) M/F [13]Denture wearers
Impaired mastication (8 male/6 female)
Not mentionedMuscle bursts were longer = lower muscle work
Muscle burst decreased significantly for denture wearers
Longer chewing duration
Food boli were less disorganized
N/AN/AN/AChewing of paraffin and meatN/AImpaired chewing in complete denture wearers modifies the dynamics of meat bezoar formation due to large fragmented bolus
(14) 44/F [14]Irritable bowel syndrome
Consumption of large quantities of honeycomb for health benefits
Epigastric pain
NoneBodyN/AN/AHoneycombEndoscopic removal
100 ml of hydrogen peroxide
Modified and conventional needle-knife
Snares and baskets
(15) 69/F [12]Cholelithiasis
Right-sided upper abdominal pain
Nausea and vomiting
Multiple biliary stones in the common bile ductPylorus and duodenal bulbN/AN/AGallstones and indigestible materialProton pump inhibitor and cola drinkNone
(16) 14/F [17]Anorexia nervosa
Thalassemia trait and growth hormone replacement.
Nausea and vomitingWeight loss
Nontender, large, firm, left upper quadrant mass
(entire stomach and duodenum)
N/ANoneHair (trichobezoar)LaparotomyNone
(17) 45/F [15]Habitual consumption of cows’ feet stew with hair and skin intact.
Previous history of gastric bezoar via laparotomy
Abdominal distension
Abdominal pain
Shortness of breath
Generalized weakness
Microcytic anemia
Lesser curvature2.42 kgUlcer at the lesser curvatureMass of hair
Leathery skin and altered food (trichobezoar)
(18) 19/F [16]Anorexia nervosa
Nausea and vomiting
Weight loss
Parotid hypertrophy bilaterally
Vomited a cylindrical bezoar from the stomach4 cmPossible erosions or ulcerDebris and birefringent
Foreign material
Vegetable matter
Conservative treatmentN/A
(19) 21/F [18]Bulimia nervosa
Binge eating episodes
Abdominal pain
Afebrile, normotensive with mild tachycardia
Distended abdomen
Weight loss
Greater curvature overlying the pylorusNoneFood matterCoca-Cola
(20) 3/F [19]Sickle cell diseaseUpper abdominal pain
Nonbilious emesis
Large intra-abdominal mass epigastric tenderness
Hemoglobin 9.6 g/dL
Leukocyte Polymorphonuclear leukocyte 69%
Platelet 254,000/μL
Stomach extended to the duodenumN/ATrichobezoarLaparotomy
(21) 62/F [51]Multiple myelomaEpigastric pain
Weight loss
Elevated IgG of 49.2 g/L
Low IgM and IgA levels IgG
Lambda paraprotein 35 g/L
Lambda Bence-Jones protein in the urine, elevated β2-microglobulin 5.50 mg/mL
Body extended pylorusN/AMild focal intestinal metaplasia and glandular atrophyPhytobezoarCoca-Cola pancreatic enzyme supplementationExpired in 1 month
(22) 42/F [39]Hypertension
Type 2 diabetes mellitus
Peripheral neuropathy
Nausea and vomiting
Abdominal pain
Obese, epigastric tenderness
Significant distress
Abdominal distension
Hypoactive bowel sounds
AntrumN/ACholesterol gallstone induced bezoarLaparotomy
(23) 34/F [42]Laparoscopic adjustable gastric bandingEpigastric fullness
Nausea and vomiting
BMI 37 kg/m2
In eccentric pouch dilatationN/AN/ABezoarLiquid diet
Anterolateral slippage of the band
(24) 48/M [43]Laparoscopic adjustable gastric bandingDysphagiaN/ABodyN/AErosionsPhytobezoarPapain (1 week)None
(25) 70/M [54]Cholecystogastric fistulaPainful lump in the right hypochondriac region with fever and anorexiaCT revealed fistula between the gallbladder and gastric antrum.AntrumFistulous opening in the prepyloric regionGallstone bezoar
 (cholesterol and calcium oxalate)
(26) 63/F [56]Roux-en-Y gastric bypassAbdominal distention
Nausea and vomiting
Morbid obese (body mass index 49.5 kg/m2)
14 months postsurgery BMI 28 kg/m2
Gastric pouch5 cmNonePersimmon
Biopsy snare
(27) 65/M [58]Chestnuts consumptionAbdominal painAbdominal CT indicated gastric perforationLesser curvatureN/AUlcerTannin
Chestnut bezoars
Gastric perforation
(28) 73M/58F [59](2 cases)
(1) Billroth I partial gastrectomy for gastric cancer.
(2) Laparoscopic adjustable gastric banding
Proximal gastric pouch10 cm
8 cm
N/APhytobezoar200 micron laser fiber and 550 micron laser fiber (Ho:YAG laser)None
(29) 62/F [61]Acute gastritis and gallstonesEpigastric pain
Nausea and vomiting
Dark loose stools
Abdominal tenderness
Positive Murphy sign
Hyperactive bowel sounds
Pale tongue
Occult blood in the vomit
BodyN/AGastric angle with multiple lesions
Gastric ulcers
Venous aneurysm
BezoarChinese medicine purgative combined with pantoprazole sodium intravenous infusion, 40  mg each time, twice a day for 5 daysNone

A/G: age/gender; M: male; F: female; NA: not available; cm: centimeter.

An abdominal examination has limited the efficacy in identifying gastric masses; though, sometimes on abdominal palpation intragastric mass or halitosis from the putrefying items can be found. However, these observations are not definitive and much harder to differentiate.

Upper GI series is the first step in diagnosis gastric bezoar if suspected. Appearance on CT is a mass-like filling defect with various composition-dependent characteristics. Trichobezoars often have a lamellated appearance. The gold standard for imaging is direct visualization with upper GI endoscopy for both diagnostic and therapeutic purposes [1, 14].

5. Management

Gastric bezoars can be managed either medicinally, endoscopic, or surgically. Bezoars with small size may pass via the GI tract freely on their own. In the management of gastric bezoars, there are three most common approaches which mostly focus on dissolution or eliminating bezoars. (1) Enzymatic treatment (Coca-Cola irrigations, gastroprokinetic agents, and enzymes cellulose) [4, 5, 18]. (2) Endoscopic management as the mainstream treatment includes (biopsy and alligator forceps, lithotripters, needle cutter, snares of polypectomy, and lithotripsy with Nd:YAG laser-ignited mini-explosive procedure) [4, 59]. (3) However, surgical management is the best technique for bigger ones. Recently, a laparoscopic procedure with Alexis wound retractor was effectively used in the management of bezoars [2, 4, 60]. More recently, holmium:YAG (Ho:YAG) laser lithotripsy for giant bezoar and a laparoscopic technique with endobag in the stomach to prevent bezoar spillage have shown promising results [59]. Traditional Chinese medicine purgative has also shown effectiveness in the dissolution of giant gastric bezoar and associated gastric lesions [61]. Furthermore, psychiatric treatment and dietetic instruction are suggested.

6. Conclusions

Gastric bezoars most frequently occur in patients with certain risk factors including psychiatric conditions, anatomic anomalies, and weakened gastric motility or in patients with coexisting medical conditions. Early diagnosis and appropriate treatment strategy are essential to prevent bezoar-induced complications. Upper GI endoscopy is a safe and effective procedure for diagnostic and therapeutic purposes of gastric bezoars. Besides, careful endoscopic surveillance should be carried out if the bezoars recur repeatedly, especially in patients with anatomical abnormalities or previous gastric surgeries. There could be a number of other contributing factors that can lead to gastric bezoar but have not yet been known to the clinicians. However, further studies are required to address this issue.



Conflicts of Interest

The authors report no conflicts of interest.

Authors’ Contributions

All the names of the persons who have made substantial contributions to the work reported in the manuscript are declared in the author list. SK contributed to the paper in writing, data collection, data analysis, and manuscript preparation. KJ and LZ contributed in literature search and in the definition of intellectual content. IAK, KU, and SK contributed to the final review. XC and BMW contributed to the study concept, design, manuscript editing, and manuscript review. All authors read and approved the final manuscript.


This work was supported by the Science and Technology Program of Tianjin (15ZXJZSY00020) and the Natural Science Foundation of Tianjin (18JCZDJC45200).


  1. S. Khan, I. A. Khan, K. Ullah et al., “Etiological aspects of intragastric bezoars and its associations to the gastric function implications: a case report and a literature review,” Medicine, vol. 97, no. 27, article e11320, 2018. View at: Publisher Site | Google Scholar
  2. J. S. Parakh, A. McAvoy, and D. J. Corless, “Rapunzel syndrome resulting in gastric perforation,” Annals of the Royal College of Surgeons of England, vol. 98, no. 1, pp. e6–e7, 2016. View at: Publisher Site | Google Scholar
  3. M. Gachabayov, A. Abdullaev, P. Mityushin, and T. Gilyazov, “Each worm to his taste: some prefer to eat nettles – a giant gastric phytobezoar,” Clinical Case Reports, vol. 4, no. 7, pp. 710-711, 2016. View at: Publisher Site | Google Scholar
  4. I. Ugenti, E. Travaglio, E. Lagouvardou, O. Caputi Iambrenghi, and G. Martines, “Successful endoscopic treatment of gastric phytobezoar: a case report,” International Journal of Surgery Case Reports, vol. 37, pp. 45–47, 2017. View at: Publisher Site | Google Scholar
  5. S. D. Ladas, D. Kamberoglou, G. Karamanolis, J. Vlachogiannakos, and I. Zouboulis-Vafiadis, “Systematic review: Coca-Cola can effectively dissolve gastric phytobezoars as a first-line treatment,” Alimentary Pharmacology & Therapeutics, vol. 37, no. 2, pp. 169–173, 2013. View at: Publisher Site | Google Scholar
  6. M. Iwamuro, H. Okada, K. Matsueda et al., “Review of the diagnosis and management of gastrointestinal bezoars,” World Journal of Gastrointestinal Endoscopy, vol. 7, no. 4, pp. 336–345, 2015. View at: Publisher Site | Google Scholar
  7. P. Heinz-Erian, I. Gassner, A. Klein-Franke et al., “Gastric lactobezoar - a rare disorder?” Orphanet Journal of Rare Diseases, vol. 7, no. 1, pp. 3–3, 2012. View at: Publisher Site | Google Scholar
  8. L. Castro, A. Berenguer, C. Pilar, R. Goncalves, and J. L. Nunes, “Recurrent gastric lactobezoar in an infant,” Oxford Medical Case Reports, vol. 2014, no. 4, pp. 80–82, 2014. View at: Publisher Site | Google Scholar
  9. A. L. Briggs and L. L. Deal, “Endoscopic removal of pharmacobezoar in case of intentional potassium overdose,” The Journal of Emergency Medicine, vol. 46, no. 3, pp. 351–354, 2014. View at: Publisher Site | Google Scholar
  10. M. Croitoru, A. Shouval, D. Chepurov, and Y. Katz, “Giant intragastric sodium polystyrene sulfonate bezoar,” Kidney International, vol. 88, no. 2, p. 415, 2015. View at: Publisher Site | Google Scholar
  11. P. P. Karnik, N. M. Dave, and M. Garasia, “Large gastric wood bezoar: anesthesia implications,” Journal of Anaesthesiology Clinical Pharmacology, vol. 32, no. 3, pp. 400-401, 2016. View at: Publisher Site | Google Scholar
  12. M. Sarikaya, E. Koçak, S. Köklü, and E. Akbal, “Acute gastric obstruction resulting from gallstone-induced bezoar,” The American Surgeon, vol. 78, no. 12, article E529, 2012. View at: Google Scholar
  13. C. Yven, L. Bonnet, D. Cormier, S. Monier, and L. Mioche, “Impaired mastication modifies the dynamics of bolus formation,” European Journal of Oral Sciences, vol. 114, no. 3, pp. 184–190, 2006. View at: Publisher Site | Google Scholar
  14. P. Katsinelos, I. Pilpilidis, G. Chatzimavroudis et al., “Huge gastric bezoar caused by honeycomb, an unusual complication of health faddism: a case report,” Cases Journal, vol. 2, no. 1, p. 7077, 2009. View at: Publisher Site | Google Scholar
  15. M. F. Kiernan, S. Kamat, and F. Olagbaiye, “Cows-feet soup: a rare cause of recurrent trichobezoar,” Case Reports, vol. 2012, 2012. View at: Publisher Site | Google Scholar
  16. C. Laird Birmingham, S. Cardew, and S. Gritzner, “Gastric bezoar in anorexia nervosa,” Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, vol. 12, no. 2, pp. e28–e29, 2007. View at: Publisher Site | Google Scholar
  17. N. E. Saldanha, J. A. Meisel, J. M. Prince, R. Feinstein, and M. Fisher, “Delayed diagnosis of trichobezoar in a patient with presumed anorexia nervosa,” International Journal of Adolescent Medicine and Health, vol. 27, no. 3, pp. 349–352, 2015. View at: Publisher Site | Google Scholar
  18. R. M. Fazio, P. Shah, E. Soe, K. Iswara, and I. Chen, “Gastric bezoar causing massive gastric distention and functional outlet obstruction in a patient with bulimia nervosa,” Journal of Medical Cases, vol. 7, no. 7, pp. 312–314, 2016. View at: Publisher Site | Google Scholar
  19. J. D. Sciarretta and S. J. Bond, “Gastric trichobezoar: abdominal mass in a child with sickle cell disease,” Pediatric Emergency Care, vol. 27, no. 11, pp. 1014-1015, 2011. View at: Publisher Site | Google Scholar
  20. A. S. Y. Lee, D. Z. Q. Lee, and F. F. Vasanwala, “Amyloid light-chain amyloidosis presenting as abdominal bloating: a case report,” Journal of Medical Case Reports, vol. 10, no. 1, p. 68, 2016. View at: Publisher Site | Google Scholar
  21. F. Stofer, M. F. Barretto, A. L. Gouvea et al., “A rare case of ascites due to peritoneal amyloidosis,” American Journal of Case Reports, vol. 17, pp. 439–443, 2016. View at: Publisher Site | Google Scholar
  22. T. Ong, S. G. Marshall, B. A. Karczeski, D. L. Sternen, E. Cheng, and G. R. Cutting, “Cystic Fibrosis and Congenital Absence of the Vas Deferens,” in GeneReviews(R), R. A. Pagon, M. P. Adam, H. H. Ardinger et al. et al., Eds., University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle, Seattle WA, 1993. View at: Google Scholar
  23. M. Colantuoni, E. Matano, S. Alfieri, S. De Placido, and C. Carlomagno, “Guillain-Barre syndrome associated with gastric cancer: paraneoplastic syndrome or immunological disorder?” World Journal of Oncology, vol. 1, no. 6, pp. 247–249, 2010. View at: Publisher Site | Google Scholar
  24. S. M. Qamrul Arfin, S. A. Haqqi, H. Shaikh, and A. J. Wakani, “Bouveret’s syndrome: successful endoscopic treatment of gastric outlet obstruction caused by an impacted gallstone,” Journal of the College of Physicians and Surgeons Pakistan, vol. 22, no. 3, pp. 174-175, 2012. View at: Google Scholar
  25. T. C. Foets, B. L. Weusten, H. W. van Es, and D. Boerma, “An 84 year old man with gastric outlet obstruction,” Nederlands Tijdschrift voor Geneeskunde, vol. 158, article A7550, 2014. View at: Google Scholar
  26. K. Soga, K. Kassai, K. Itani, N. Yagi, Y. Naito, and Y. Itoh, “Gastric outlet obstruction induced by a gastric wall abscess after cholecystitis,” Internal Medicine, vol. 53, no. 23, pp. 2675–2678, 2014. View at: Publisher Site | Google Scholar
  27. L. R. Kaplan, “Hypothyroidism presenting as a gastric phytobezoar,” American Journal of Gastroenterology, vol. 74, no. 2, 1980. View at: Google Scholar
  28. E. S. Hirata, M. A. Mesquita, G. Alves Filho, and C. H. Terra, “O esvaziamento gástrico e a insuficiência renal crônica,” Revista Brasileira de Anestesiologia, vol. 57, no. 4, 2007. View at: Publisher Site | Google Scholar
  29. S. Shirazian and J. Radhakrishnan, “Gastrointestinal disorders and renal failure: exploring the connection,” Nature Reviews. Nephrology, vol. 6, no. 8, pp. 480–492, 2010. View at: Publisher Site | Google Scholar
  30. M. M. Piskorz, G. Rank, M. Velazquez Espeche et al., “Usefulness of gastric emptying scintigraphy for the evaluation and management of scleroderma related gastroparesis,” Acta Gastroenterologica Latinoamericana, vol. 45, no. 1, pp. 56–60, 2015. View at: Google Scholar
  31. V. Nagaraja, Z. H. McMahan, T. Getzug, and D. Khanna, “Management of gastrointestinal involvement in scleroderma,” Current Treatment Options in Rheumatology, vol. 1, no. 1, pp. 82–105, 2015. View at: Publisher Site | Google Scholar
  32. C. M. Lo Cascio, O. Goetze, T. D. Latshang, S. Bluemel, T. Frauenfelder, and K. E. Bloch, “Gastrointestinal dysfunction in patients with Duchenne muscular dystrophy,” PLoS One, vol. 11, no. 10, article e0163779, 2016. View at: Publisher Site | Google Scholar
  33. A. Fois, “Gastrointestinal disorders in muscular dystrophies,” Journal of Pediatric Gastroenterology and Nutrition, vol. 25, p. 20, 1997. View at: Publisher Site | Google Scholar
  34. K. M. Anandpara, Y. Aswani, and P. Hira, “An unusual association of Menetrier’s disease with a gastric bezoar,” Case Reports, vol. 2015, 2015. View at: Publisher Site | Google Scholar
  35. M. Podda, J. Atzeni, A. Messina Campanella, A. Saba, and A. Pisanu, “Syncope with surprise: an unexpected finding of huge gastric diverticulum,” Case Reports in Surgery, vol. 2016, Article ID 1941293, 5 pages, 2016. View at: Publisher Site | Google Scholar
  36. B. T. Moy, R. M. M. Beery, and J. W. Birk, “Gastric diverticulum: an unusual endoscopic finding,” ACG Case Reports Journal, vol. 3, no. 3, pp. 150-151, 2016. View at: Publisher Site | Google Scholar
  37. J. Holder, D. Zinn, and A. Samin, “Adult-onset idiopathic hypertrophic pyloric stenosis associated with osteoglophonic dysplasia and HIV: case report and review of literature,” Ultrasound Quarterly, vol. 33, no. 1, pp. 77–81, 2017. View at: Publisher Site | Google Scholar
  38. J. U. Lee, M. S. Park, S. H. Yun et al., “Risk factors and management for pyloric stenosis occurred after endoscopic submucosal dissection adjacent to pylorus,” Medicine, vol. 95, no. 50, article e5633, 2016. View at: Publisher Site | Google Scholar
  39. G. M. Tadros, J. M. Draganescu, L. E. Clarke, and A. M. Albornoz, “Intragastric gallstone-induced bezoar: an unusual cause of acute gastric outlet obstruction,” Southern Medical Journal, vol. 95, no. 2, pp. 261–264, 2002. View at: Publisher Site | Google Scholar
  40. M. K. Mohammad, D. J. Pepper, A. Kedar et al., “Measures of autonomic dysfunction in diabetic and idiopathic gastroparesis,” Gastroenterology Research, vol. 9, no. 4-5, pp. 65–69, 2016. View at: Publisher Site | Google Scholar
  41. N. Liu and T. Abell, “Gastroparesis updates on pathogenesis and management,” Gut and Liver, vol. 11, no. 5, pp. 579–589, 2017. View at: Publisher Site | Google Scholar
  42. R. Parameswaran, J. Ferrando, and A. Sigurdsson, “Gastric bezoar complicating laparoscopic adjustable gastric banding with band slippage,” Obesity Surgery, vol. 16, no. 12, pp. 1683-1684, 2006. View at: Publisher Site | Google Scholar
  43. C. Cortes and C. Silva, Revista Medica de Chile, vol. 136, no. 11, pp. 1457–1459, 2008, Gastric bezoar as complication of gastric banding. Report of one case.
  44. S. Krishnasamy and T. L. Abell, “Diabetic gastroparesis: principles and current trends in management,” Diabetes Therapy, vol. 9, Supplement 1, pp. 1–42, 2018. View at: Publisher Site | Google Scholar
  45. M. Akrami and M. R. Sasani, “Dietary habits affect quality of life: bowel obstruction caused by phytobezoar,” Iranian Journal of Public Health, vol. 45, no. 8, pp. 1080–1082, 2016. View at: Google Scholar
  46. H. H. Hsu, W. E. Grove, R. Mindulzun, and C. M. Knauer, “Gastric bezoar caused by lecithin: an unusual complication of health faddism,” The American Journal of Gastroenterology, vol. 87, no. 6, pp. 794–796, 1992. View at: Google Scholar
  47. M. A. Mazid, “Medication bezoar causing acute gastric outlet obstruction: a case report,” Journal of Bangladesh College of Physicians and Surgeons, vol. 33, no. 3, pp. 177–180, 2016. View at: Publisher Site | Google Scholar
  48. S. A. Jain, L. Agarwal, A. Khyalia, P. Chandolia, and H. Kaknale, “Pharmacobezoar—a rare case presented as gastric outlet obstruction,” Journal of Surgical Case Reports, vol. 2018, no. 5, 2018. View at: Publisher Site | Google Scholar
  49. B. J. Tabaac and V. Tabaac, “Pica patient, status post gastric bypass, improves with change in medication regimen,” Therapeutic Advances in Psychopharmacology, vol. 5, no. 1, pp. 38–42, 2015. View at: Publisher Site | Google Scholar
  50. X. Lin, Y. Mao, Q. Qi, C. Zhang, Y. Tian, and Y. Chen, “Primary systemic amyloidosis initially presenting with digestive symptoms: a case report and review of the literature,” Diagnostic Pathology, vol. 10, no. 1, p. 174, 2015. View at: Publisher Site | Google Scholar
  51. E. S. Appleton, N. A. Lee, and A. C. Ford, “Multiple myeloma presenting in association with gastric phytobezoar,” Clinical Case Reports, vol. 5, no. 9, pp. 1493–1495, 2017. View at: Publisher Site | Google Scholar
  52. Y.-I. Lee and S.-K. Lee, “Endoscopic submucosal dissection of an inverted early gastric cancer-forming false gastric diverticulum,” Clinical Endoscopy, vol. 49, no. 1, pp. 86–90, 2016. View at: Publisher Site | Google Scholar
  53. J. Zhu, T. Zhu, Z. Lin, Y. Qu, and D. Mu, “Perinatal risk factors for infantile hypertrophic pyloric stenosis: a meta-analysis,” Journal of Pediatric Surgery, vol. 52, no. 9, pp. 1389–1397, 2017. View at: Publisher Site | Google Scholar
  54. S. N. Purandare, B. Patil, M. Chakane, and S. E. Jadhav, “Gallstone bezoar following cholecystogastric fistula: a rare sequelae of cholelithiasis,” Indian Journal of Surgery, vol. 77, no. S3, pp. 1403-1404, 2015. View at: Publisher Site | Google Scholar
  55. D. Pinto, L. Carrodeguas, F. Soto et al., “Gastric bezoar after laparoscopic Roux-en-Y gastric bypass,” Obesity Surgery, vol. 16, no. 3, pp. 365–368, 2006. View at: Publisher Site | Google Scholar
  56. I. Ertugrul, A. Tardum Tardu, K. Tolan, C. Kayaalp, S. Karagul, and S. Kirmizi, “Gastric bezoar after Roux-en-Y gastric bypass for morbid obesity: a case report,” International Journal of Surgery Case Reports, vol. 23, pp. 112–115, 2016. View at: Publisher Site | Google Scholar
  57. T. Ben-Porat, S. Sherf Dagan, A. Goldenshluger, J. B. Yuval, and R. Elazary, “Gastrointestinal phytobezoar following bariatric surgery: systematic review,” Surgery for Obesity and Related Diseases, vol. 12, no. 9, pp. 1747–1754, 2016. View at: Publisher Site | Google Scholar
  58. Y. Okagawa, K. Takada, Y. Arihara, and J. Kato, “A case of gastric perforation caused by chestnut bezoars,” Nihon Shokakibyo Gakkai Zasshi= The Japanese Journal of Gastro-Enterology, vol. 114, no. 10, pp. 1830–1835, 2017. View at: Publisher Site | Google Scholar
  59. G. Grande, M. Manno, C. Zulli et al., “An alternative endoscopic treatment for massive gastric bezoars: Ho:YAG laser fragmentation,” Endoscopy, vol. 48, article E217, Supplement 01, 2016. View at: Publisher Site | Google Scholar
  60. E. C. G. Tudor and M. C. Clark, “Laparoscopic-assisted removal of gastric trichobezoar; a novel technique to reduce operative complications and time,” Journal of Pediatric Surgery, vol. 48, no. 3, pp. e13–e15, 2013. View at: Publisher Site | Google Scholar
  61. Q. Dai and F. Jiang, “A huge gastric bezoar treated by traditional Chinese medicine purgative: a case report,” Medicine, vol. 97, no. 50, article e13712, 2018. View at: Publisher Site | Google Scholar

Copyright © 2019 Samiullah Khan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

2456 Views | 431 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.